Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis (Q24671749)

2

0 references

A K Eckstein

3

0 references

R Vonthein

4

0 references

T Ness

5

0 references

I Günaydin

6

0 references

B Grimbacher

7

0 references

S Blaschke

8

0 references

W Meyer-Riemann

9

0 references

H H Peter

10

0 references

N Stübiger

British Journal of Ophthalmology

11

0 references

language of work or name

English

0 references

publication date

April 2003

0 references

published in

0 references

volume

87

0 references

page(s)

423-31

0 references

issue

4

0 references

cites work

HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Interferon therapy and autoimmunity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Therapy of Behçet's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Interferon alfa-2a in the treatment of Behçet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Behçet's disease induced by interferon therapy for chronic myelogenous leukemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Treatment and visual prognosis in Behçet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

A controlled trial of azathioprine in Behçet's syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Behçet disease (Behçet syndrome)

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Efficacy and safety of systemic recombinant interferon-alpha in Behçet's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

The concurrence of lupus and fibromyalgia: implications for diagnosis and management

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Azathioprine in Behcet's syndrome: effects on long-term prognosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Systemic interferon alpha 2b treatment in Behçet's syndrome.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Effectiveness of cyclosporin therapy for Behçet's disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Clinical differentiation of oral ulceration in Behçet's disease.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Ocular prognosis in Behçet's disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

RETRACTED: Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Cyclosporin-A therapy in severe uveitis of Behçet's disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Severe necroziting vasculitis in a patient with hepatitis C virus infection treated by interferon

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Parvovirus B19 infection in Behçet's disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

[Adamantiades-Behçet disease. Therapeutic administration of systemic recombinant interferon-alpha-2a].

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1771623

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

28 November 2018

1 reference

12 December 2020

Behçet's syndrome: treatment with recombinant leukocyte alpha-interferon

1 reference

12 December 2020

Interferon-associated retinopathy

1 reference

12 December 2020

Interferon-alpha and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells

1 reference

12 December 2020

Behçet's disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Behçet's symptoms

1 reference

12 December 2020

Epidemiological features and visual prognosis of Behçet's disease

1 reference

12 December 2020

1 reference

12 December 2020

Behçet's disease and interferon: flaws in research integrity of randomised trial

1 reference

12 December 2020

Immunological studies of gamma delta T cells in a case of large granular lymphocyte (LGL) leukemia: leukemic gamma delta+ T cells are resistant to growth stimulation in vitro but respond to interferon-alpha treatment in vivo

1 reference

12 December 2020

Interferon therapy for Behçet's disease

1 reference

12 December 2020

Autoantibodies during alpha-interferon therapy for chronic hepatitis B

1 reference

12 December 2020

Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders

1 reference

12 December 2020

Retinal complications during interferon therapy for chronic hepatitis C

1 reference

12 December 2020

Treatment of Behçet's disease

1 reference

12 December 2020

Psoriasis and alpha-interferon

1 reference

12 December 2020

The neglected role of type I interferon in the T-cell response: implications for its clinical use

1 reference

12 December 2020

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

12 December 2020

Beneficial effects of interferon-alpha 2b in Behçet's disease

1 reference

12 December 2020

Interferon-alpha treatment of Behçet's disease

1 reference

12 December 2020

Behçet's disease and interferon: flaws in research integrity of randomized trial

1 reference

12 December 2020

Anterior ischemic optic neuropathy secondary to interferon alfa

1 reference

12 December 2020

[The use of interferon alfa-2r in the treatment of autoimmune uveitis (primary or associated with Behçet's disease)]

1 reference

12 December 2020

Interferon-alpha 2b for refractory ocular Behçet's disease

1 reference

12 December 2020

Erosive arthritis and posterior uveitis in Behçet's disease: treatment with interferon alpha and interferon gamma

1 reference

12 December 2020

[Recombinant gamma interferon in psoriasis arthopathica, progressive systemic scleroderma and Behçet disease]

1 reference

12 December 2020

Retraction: Interferon alfa-2b… in Behçet's disease

1 reference

12 December 2020